Ritushree Kukreti

Title: Ritushree Kukreti: Innovator in Pharmacogenetics

Introduction

Ritushree Kukreti is a prominent inventor based in New Delhi, India. She has made significant contributions to the field of pharmacogenetics, particularly in understanding the bronchodilatory response to beta agonists. With a total of 2 patents, her work is paving the way for advancements in personalized medicine.

Latest Patents

Ritushree's latest patents include innovative methods for predicting an individual's bronchodilatory response to beta agonists. The first patent, titled "Primers for amplifying and detecting the beta 2 adrenergic receptor gene," focuses on detecting specific allelic variants of the β2AR gene. This invention serves as a pharmacogenetic marker to predict responses to β agonists. The second patent, "Method of detecting and predicting bronchodilatory response to beta agonist," further elaborates on the same theme, emphasizing the importance of genetic variations in therapeutic responses.

Career Highlights

Throughout her career, Ritushree has worked with esteemed organizations such as the Council of Scientific and Industrial Research and Piramal Life Sciences Limited. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Ritushree has collaborated with notable colleagues, including Pallav Bhatnagar and Chandrika Rao. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Ritushree Kukreti's innovative work in pharmacogenetics is making a significant impact on personalized medicine. Her patents are crucial for understanding individual responses to medication, which can lead to more effective treatments.